Related to this topic: Leaflets | Patient+ | Diagrams | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Assessing Lymphadenopathy

Lymphadenopathy may be localised or generalised. The cause of lymphadenopathy is often obvious and is usually a result of a benign infectious cause. Most patients can be diagnosed on the basis of a careful history and physical examination. Generalised adenopathy should always prompt further clinical investigation.1

Causes
Presentation
  • Localised lymphadenopathy should prompt a search for an adjacent precipitating lesion and an examination of other nodal areas to rule out generalised lymphadenopathy.2
  • Lymph nodes greater than 1 cm in diameter are generally considered to be abnormal.1
  • History of malaise and weight loss may be associated with malignancy or certain infections, e.g. HIV, tuberculosis.
  • Painful, tender lymph nodes are usually associated with infection.
  • Firm or hard, painless nodes are often associated with malignancy.
  • Full examination is essential and may reveal associated bruising (e.g. leukaemia) or hepatosplenomegaly (e.g. lymphoma).
Differential Diagnosis

See Neck Lumps and Bumps

  • Lipomas
  • Branchial cleft cysts
  • Cystic hygromas
  • Salivary glands
  • Thyroglossal duct cysts - usually in midline
Investigations

Will be governed by the history and examination and likely cause of lymphadenopathy. Investigations may not be required in cases of obvious cause and quick resolution with or without treatment.

  • Full blood count: white cell count raised in infection or malignancy, blood film for leukaemia
  • Acute phase reactants, e.g. ESR and CRP, often raised in infection or malignancy
  • Liver function tests: liver infiltration
  • Infection:
    • Swabs from primary infection site for culture and sensitivities
    • Viral titres, e.g. Epstein-Barr, HIV
    • Mantoux test: tuberculosis
    • VDRL: syphilis
    • Toxoplasma screen
    • Blood cultures
  • Autoantibody screen: SLE, rheumatoid arthritis
  • Kveim test: sarcoidosis
  • Chest x-ray: sarcoidosis, tuberculosis, primary or secondary malignancy
  • CT scan: nodal distribution, staging of lymphoma
  • Fine needle aspiration or biopsy of lymph node may be required
  • Sentinel node biopsy:
    • The sentinel node is the first node identified or the node with the highest radioactivity count.
    • Sentinel node biopsy can avoid the need for block dissection of lymph nodes. It is often used in the pre-operative assessment of breast cancer and melanoma and may have benefits in other cancers.
    • The sentinel node can be identified either by local injection of blue dye and following its path, or by gamma camera imaging following injection of 99mTc.
Assessment and Management

The following factors should be considered:

  • Careful reappraisal of the history, and full examination is required, determining the size and character of node(s).
  • In the absence of obvious infection or an underlying disorder, or any suspicion of malignancy - refer.
  • Bilateral anterior cervical nodes up to 2cm are often found in healthy children and adults after recent URTIs.
  • Dependent on level of doctor's concern, empirical treatment with antibiotics (usually ant-staph/strep) may be tried, with reevaluation in 2-4 weeks. If unchanged, or larger - refer.
  • Some patients, particularly children, remain undiagnosed after biopsy.
  • In studies of 9-25yr olds, Size >2cm and an abnormal CXR indicated a greater risk of a sinister cause, and recent ENT symptoms suggested a reduced risk of a sinister cause.
  • In another study >40yr olds, >1.5x1.5cm, supraclavicular location, hard consistency, and lack of tenderness or pain showed a positive predictive value of a sinister cause; <40yrs, size <1.0x1.0cm, non-hard consistency, tenderness or pain, showed a negative predictive value of a sinister cause.


Document References
  1. Ferrer R; Lymphadenopathy: Differential Diagnosis and Evaluation. American Family Physician; October 15 1998.
  2. Gow K; Lymph Node Disorders. eMedicine, March 2006.

Internet and Further Reading
  • Kanwar VS; Lymphadenopathy. eMedicine May 2006.
Acknowledgements EMIS is grateful to Dr Colin Tidy for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 1827
Document Version: 20
DocRef: bgp1828
Last Updated: 1 Oct 2007
Review Date: 30 Sep 2009




















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page